How do we deal with dissection after angioplasty?

Journal of Endovascular Therapy

Volumn 20, Issue 6, 2013, Pages 801-804

  Fanelli, Fabrizio ^a   Cannavale, Alessandro ^a   Gazzetti, Marianna ^a   D'Adamo, Alessandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PACLITAXEL; BIOMATERIAL; CARDIOVASCULAR AGENT;

ARTERIAL STENT; ARTERY CALCIFICATION; ARTERY DISSECTION; ARTERY INJURY; ARTERY THROMBOSIS; BALLOON CATHETER; BLOOD VESSEL WALL; DRUG EFFECT; FOLLOW UP; HUMAN; HYPERPLASIA; IN-STENT RESTENOSIS; MATERIAL COATING; NOTE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY STENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY STENT; SURGICAL TECHNIQUE; VASODILATATION; CENTRAL VENOUS CATHETER; DISSECTING ANEURYSM; EQUIPMENT; FEMALE; FEMORAL ARTERY; MALE; POPLITEAL ARTERY;

ANEURYSM, DISSECTING; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FEMORAL ARTERY; HUMANS; MALE; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; VASCULAR ACCESS DEVICES;

EID: 84890085131     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4392C.1     Document Type: Note

References (14)

1. Tendera M, Aboyans V, Bartelink ML, et al.; ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.
2. Rooke TW, Hirsch AT, Misra S, et al.; American College of Cardiology Foundation; American Heart Association; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv. 2012;79:501-531.
3. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64-70
4. van Lankeren W, Gussenhoven EJ, Honkoop J, et al. Plaque area increase and vascular remodeling contribute to lumen area change after percutaneous transluminal angioplasty of the femoropopliteal artery: an intravascular ultrasound study. J Vasc Surg. 1999;29:430-441.
5. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012;19:1-9.
6. Tepe G, Zeller T, Schnorr B, et al. High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther. 2013;20:792-800.
7. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
8. Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012;19:571-580.
9. Werk M, Albrecht T, Meyer DR, et al. Paclitaxelcoated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831-840.
10. Micari A, Cioppa A, Vadalà G, et al. Clinical evaluation of paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv. 2012;5:331-338.
11. Wakman R, Pakala R. Drug-eluting balloon: the comeback kid? Circ Cardiovasc Interv. 2009;2:352-358.
12. Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. 1983;67:723-730.
13. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105-1109.
14. Liistro F, Porto I, Angioli P, et al. Drug-Eluting Balloon in peripherAl inTErvention for Below The Knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013;128;615-621.